Bixiye
QP98-22 Commercial Pharmacy Benefit Exclusion for Cimerli™, Skysona®, Spevigo®, and Xenpozyme™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Natiijooyinka Raadinta
Soo bandhiga 1591 - 1600 ee natiijooyinka 3688
Bixiye
QP97-22 Update for New to Market Medical Drugs: etranacogene dezaparvovec
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Bixiye
P75-22 Update to 2023 Renewal Changes Summaries for BP PCC & Institutional Providers
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2022
Bixiye
Vtama (tapinarof) - Medicaid
Oggolaanshaha Hore
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Camzyos™ (mavacamten) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
P74-22 Update to Claims Timely Filing Limits and Appeal Submission Timeframes
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2022
Bixiye
P76-22 No-Load Miles (Deadhead) Reimbursement Rate for Minnesota Health Care Programs Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2022
Bixiye
P77-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective January 30, 2023
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023
Bixiye
P79-22 Reimbursement Rate Changes for Psychotherapy Codes 90837 and 90838
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2022